Main content

Welcome at Center for Radiopharmaceutical Sciences

Radioactively labeled compounds (radiopharmaceuticals) are important molecular probes for the non-invasive detection of diseases with very high sensitivity. The development of radiopharmaceuticals in an interdisciplinary endeavor involving radiochemistry, radiopharmaceutical chemistry, biochemistry, molecular biology, pharmacy and pharmacology. At the Center for Radiopharmaceutical Sciences (CRS – a joint endeavor between the ETHZ and external page Paul Scherrer Institute), our interdisciplinary team is developing and testing novel radiopharmaceuticals for the detection of neurodegeneration, cardiovascular diseases and cancer. The most promising drug candidates are transferred into our unique clean room facilities that enable aseptic drug preparation and tested in humas trials with our clinical partners.

By playing the video you accept the privacy policy of YouTube.Learn more OK

News & Events

See our latest activities.

Publications

Have a look at our latest publications.

CAS Radiopharmaceuticals

EANM-Logo

We offer a postgraduate programme that addresses chemists, pharmacists and other natural scientists working in the small-batch production or quality control of radioapharmaceuticals. Information can be found here.

Our Team

Meet our diverse team.

Infrastructure

World-class research needs state-of-the-art equipment. Have a look at our equipment.

JavaScript has been disabled in your browser